Your browser doesn't support javascript.
loading
Whole genome analysis of Gram-negative bacteria using the EPISEQ CS application and other bioinformatic platforms.
Garza-Ramos, Ulises; Rodríguez-Medina, Nadia; Córdova-Fletes, Carlos; Rubio-Mendoza, Daira; Alonso-Hernández, Christopher J; López-Jácome, Luis Esaú; Morfín-Otero, Rao; Rodríguez-Noriega, Eduardo; Rojas-Larios, Fabián; Vázquez-Larios, María Del Rosario; Ponce-de-Leon, Alfredo; Choy-Chang, Elena Victoria; Franco-Cendejas, Rafael; Martinez-Guerra, Bernardo Alfonso; Morales-de-La-Peña, Cecilia Teresita; Mena-Ramírez, Juan Pablo; López-Gutiérrez, Eduardo; García-Romo, Ricardo; Ballesteros-Silva, Bertha; Valadez-Quiroz, Alejandro; Avilés-Benítez, Laura Karina; Feliciano-Guzmán, José Manuel; Pérez-Vicelis, Talia; Velázquez-Acosta, María Del Consuelo; Padilla-Ibarra, Cecilia; López-Moreno, Laura Isabel; Corte-Rojas, Reyna Edith; Couoh-May, Carlos Antonio; Quevedo-Ramos, María Angelina; López-García, Maribel; Chio-Ortiz, Gabriela; Gil-Veloz, Mariana; Molina-Chavarria, Alejandro; Mora-Domínguez, Javier Paul; Romero-Romero, Daniel; May-Tec, Francisco Javier; Garza-González, Elvira.
Afiliação
  • Garza-Ramos U; Instituto Nacional de Salud Pública, Morelos, Mexico.
  • Rodríguez-Medina N; Instituto Nacional de Salud Pública, Morelos, Mexico.
  • Córdova-Fletes C; Facultad de Medicina, Universidad Autónoma de Nuevo León, Nuevo León, Mexico.
  • Rubio-Mendoza D; Facultad de Medicina, Universidad Autónoma de Nuevo León, Nuevo León, Mexico.
  • Alonso-Hernández CJ; Facultad de Medicina, Universidad Autónoma de Nuevo León, Nuevo León, Mexico.
  • López-Jácome LE; Instituto Nacional de Rehabilitación Luis Guillermo Ibarra, Ciudad de Mexico, Mexico.
  • Morfín-Otero R; Hospital Civil de Guadalajara Fray Antonio Alcalde, Universidad de Guadalajara, Jalisco, Mexico.
  • Rodríguez-Noriega E; Hospital Civil de Guadalajara Fray Antonio Alcalde, Universidad de Guadalajaraa, Jalisco, Mexico.
  • Rojas-Larios F; Facultad de Medicina, Universidad de Colima, Colima, Mexico.
  • Vázquez-Larios MDR; Instituto Nacional de Cardiología Ignacio Chávez, Ciudad de Mexico, Mexico.
  • Ponce-de-Leon A; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Ciudad de Mexico, Mexico.
  • Choy-Chang EV; Hospital General De Zona No.1 IMSS Nueva Frontera, Chiapas, Mexico.
  • Franco-Cendejas R; Instituto Nacional de Rehabilitación Luis Guillermo Ibarra, Ciudad de Mexico, Mexico.
  • Martinez-Guerra BA; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Ciudad de Mexico, Mexico.
  • Morales-de-La-Peña CT; Hospital General Juan María de Salvatierra, Baja California Sur, Mexico.
  • Mena-Ramírez JP; Hospital General de Zona No. 21, IMSS. Centro Universitario de los Altos, Universidad de Guadalajara. Jalisco, Mexico.
  • López-Gutiérrez E; Hospital Regional de Alta Especialidad de Oaxaca, Oaxaca, Mexico.
  • García-Romo R; Centenario Hospital Miguel Hidalgo, Aguascalientes, Mexico.
  • Ballesteros-Silva B; Centro Diagnostico Microbilógico S.A C.V, Michoacan, Mexico.
  • Valadez-Quiroz A; Hospital de Especialidades Materno Infantil de León, Guanajuato, Mexico.
  • Avilés-Benítez LK; Hospital Infantil Eva Samano de López Mateos, Michoacán, Mexico.
  • Feliciano-Guzmán JM; Hospital de Especialidades Pediátricas, Chiapas, Mexico.
  • Pérez-Vicelis T; Hospital Regional de alta especialidad Bicentenario de la independencia, Estado de México, Mexico.
  • Velázquez-Acosta MDC; Instituto Nacional de Cancerología, Ciudad de Mexico, Mexico.
  • Padilla-Ibarra C; Hospital General del Estado Dr. Ernesto Ramos Bours, Sonora, Mexico.
  • López-Moreno LI; Hospital Galenia, Quintana Roo, Mexico.
  • Corte-Rojas RE; Hospital para el Niño Poblano, Puebla, Mexico.
  • Couoh-May CA; Hospital General Dr. Agustin O`Horan, Yucatán, Mexico.
  • Quevedo-Ramos MA; Laboratorio Hospital General de León, Guanajuato, Mexico.
  • López-García M; Hospital de la Madre y del Niño Guerrerense, Chilpancingo, Guerrero, Mexico.
  • Chio-Ortiz G; Hospital General Dr. Miguel Silva, Michoacán, Mexico.
  • Gil-Veloz M; Hospital Regional de Alta Especialidad del Bajío, Guanajuato, Mexico.
  • Molina-Chavarria A; Centro Médico Dr. Ignacio Chávez ISSSTESON, Sonora, Mexico.
  • Mora-Domínguez JP; Hospital de Alta Especialidad de Veracruz, Veracruz, Mexico.
  • Romero-Romero D; Laboratorio Louis Pasteur, Toluca, Estado de México.
  • May-Tec FJ; Hospital General de Chetumal, Quintana Roo, Mexico.
  • Garza-González E; Facultad de Medicina, Universidad Autónoma de Nuevo León, Nuevo León, Mexico. Electronic address: elvira_garza_gzz@yahoo.com.
J Glob Antimicrob Resist ; 33: 61-71, 2023 06.
Article em En | MEDLINE | ID: mdl-36878463
ABSTRACT

OBJECTIVES:

To determine genomic characteristics and molecular epidemiology of carbapenem non-susceptible Klebsiella pneumoniae, Escherichia coli, Acinetobacter baumannii, and Pseudomonas aeruginosa from medical centres of Mexico using whole genome sequencing data analysed with the EPISEQⓇ CS application and other bioinformatic platforms.

METHODS:

Clinical isolates collected from 28 centres in Mexico included carbapenem-non-susceptible K. pneumoniae (n = 22), E. coli (n = 24), A. baumannii (n = 16), and P. aeruginosa (n = 13). Isolates were subjected to whole genome sequencing using the Illumina (MiSeq) platform. FASTQ files were uploaded to the EPISEQⓇ CS application for analysis. Additionally, the tools Kleborate v2.0.4 and Pathogenwatch were used as comparators for Klebsiella genomes, and the bacterial whole genome sequence typing database was used for E. coli and A. baumannii.

RESULTS:

For K. pneumoniae, both bioinformatic approaches detected multiple genes encoding aminoglycoside, quinolone, and phenicol resistance, and the presence of blaNDM-1 explained carbapenem non-susceptibility in 18 strains and blaKPC-3 in four strains. Regarding E. coli, both EPISEQⓇ CS and bacterial whole genome sequence typing database analyses detected multiple virulence and resistance genes 20 of 24 (83.3%) strains carried blaNDM, 3 of 24 (12.4%) carried blaOXA-232, and 1 carried blaOXA-181. Genes that confer resistance to aminoglycosides, tetracyclines, sulfonamides, phenicols, trimethoprim, and macrolides were also detected by both platforms. Regarding A. baumannii, the most frequent carbapenemase-encoding gene detected by both platforms was blaOXA-72, followed by blaOXA-66. Both approaches detected similar genes for aminoglycosides, carbapenems, tetracyclines, phenicols, and sulfonamides. Regarding P. aeruginosa, blaVIM, blaIMP, and blaGES were the more frequently detected. Multiple virulence genes were detected in all strains.

CONCLUSION:

Compared to the other available platforms, EPISEQⓇ CS enabled a comprehensive resistance and virulence analysis, providing a reliable method for bacterial strain typing and characterization of the virulome and resistome.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Escherichia coli / Antibacterianos Idioma: En Revista: J Glob Antimicrob Resist Ano de publicação: 2023 Tipo de documento: Article País de afiliação: México

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Escherichia coli / Antibacterianos Idioma: En Revista: J Glob Antimicrob Resist Ano de publicação: 2023 Tipo de documento: Article País de afiliação: México